Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Urology. 2012 Apr;79(4):863-8. doi: 10.1016/j.urology.2011.10.012. Epub 2011 Dec 14.
To evaluate the pathologic outcome of prostate-specific antigen-screened patients with high-grade (Gleason score ≥ 8) prostate cancer limited to 1 biopsy core, without clinical evidence of disease.
Ninety-two patients with only 1 biopsy core with cancer and treated by radical prostatectomy were divided into 4 groups according to the biopsy Gleason score: 3 + 3 = 6 (23 cases), 3 + 4 = 7 (25 cases), 4 + 3 = 7 (20 cases), and ≥ 8 (24 cases).
Cases with Gleason score ≥ 8 showed a significantly higher proportion of extraprostatic extension (50%), positive surgical margins (21%), and seminal vesicle invasion (12%) when compared with the other groups. Patients with Gleason score ≥ 8 in the biopsy had a 25-fold increased in the odds ratio for extraprostatic extension in the prostatectomy. The incidence of extraprostatic extension was higher in those with prostatic cancer involving ≥ 50% of one core (88%) compared with cases involving <50% (32%).
In patients with prostate cancer limited to 1 biopsy core, the presence of Gleason score ≥ 8 significantly increased the incidence of extraprostatic extension, positive surgical margins, and seminal vesicle invasion. The odds ratio was substantially higher in patients with ≥ 50% of Gleason ≥ 8 in the biopsy core. These data might be taken into account for proper clinical management of this set of patients.
评估仅在 1 个活检核心中发现高级别(Gleason 评分≥8)前列腺癌且无疾病临床证据的前列腺特异性抗原筛查患者的病理结局。
92 例仅在 1 个活检核心中发现癌症且接受根治性前列腺切除术的患者根据活检 Gleason 评分分为 4 组:3+3=6(23 例)、3+4=7(25 例)、4+3=7(20 例)和≥8(24 例)。
与其他组相比,Gleason 评分≥8 组的病例具有更高的前列腺外延伸(50%)、阳性手术切缘(21%)和精囊侵犯(12%)的比例。在活检中 Gleason 评分≥8 的患者中,前列腺癌在前列腺切除术中出现前列腺外延伸的几率增加了 25 倍。在一个核心中涉及≥50%的前列腺癌的病例(88%)中,前列腺外延伸的发生率高于涉及<50%的病例(32%)。
在仅 1 个活检核心中发现前列腺癌的患者中,Gleason 评分≥8 的存在显著增加了前列腺外延伸、阳性手术切缘和精囊侵犯的发生率。在活检核心中≥50%的 Gleason≥8 的患者中,比值比显著更高。这些数据可能被考虑用于对这组患者进行适当的临床管理。